SimBioSys

Chicago, IL · Founded 2017 · Privately Held (backing)

Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care. SimBioSys is based in Chicago, IL and was founded in 2017. Its last reported valuation was $39 million in Jul 2021. It has raised $21.1 million across 2 recorded rounds; the latest was a $5.2 million early-stage round in Dec 2024.

Last reported valuation
$39.0M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
Early Stage VC
Dec 2024
What is SimBioSys worth?
$39.0Mlast reported valuation · Oct 2026

SimBioSys's last reported valuation, Jul 2021. Nothing priced has surfaced since.

Free account
More of SimBioSys with a free account
  • ·The complete investor list: 11 names
  • ·Watch SimBioSys: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

SimBioSys funding history

2 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$5.2M▮
Nov 2018Debt$900K▮
Unlock post-money valuations

Membership and data by Private Market View

SimBioSys valuation

SimBioSys's last reported valuation was $39 million in Jul 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has SimBioSys raised?

SimBioSys has raised $21.1 million in total; 2 of its rounds are on record. The largest on record was a $900,000 debt round in Nov 2018; the most recent was a $5.2 million early-stage round in Dec 2024.

SimBioSys has filed 2 Form Ds with the SEC since 2018, most recently in Jan 2025 ($5.2 million sold to 13 investors).

How SimBioSys's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For SimBioSys, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about SimBioSys

What is SimBioSys worth?
SimBioSys is valued at $39.0M as of Oct 2026. SimBioSys's last reported valuation, Jul 2021. Nothing priced has surfaced since.
How much has SimBioSys raised?
SimBioSys has raised $21.1M in total funding across 2 recorded rounds.
When did SimBioSys last raise?
SimBioSys last raised in Dec 2024 (Early Stage VC), raising $5.2M.